Nerve Repair and Regeneration Key Players and their Developments
The global nerve repair and regeneration market size is calculated at USD 10.25 billion in 2024, grew to USD 11.5 billion in 2025, and is projected to reach around USD 32.4 billion by 2034. The market is expanding at a CAGR of 12.2% between 2024 and 2034.
Top Companies in the Nerve Repair and Regeneration Market
- Abbott Laboratories
- AxoGen, Inc.
- Baxter International
- Boston Scientific Corporation
- Integra Lifesciences
- Medtronic
- NeuroPace
- Nuvectra Corporation
- Polyganics Holding
- Regenity Biosciences
- Stryker Corporation
Latest Announcement by Industry Leaders
Paul Anderson, Managing Director, Orthocell Ltd., reported the June quarter revenue of $1.84 million, an increase of 14.4% from the previous quarter and a 10% increase from last year. He said that the surge in revenue was due to Orthocell’s market-leading products Striate+, a non-invasive treatment for dental bone regeneration, and Remplir, a game-changing solution for people with damaged nerves or peripheral nerve pain.
Recent Developments in the Nerve Repair and Regeneration Market
- In October 2024, researchers from the Hong Kong University of Science and Technology highlighted the role of a novel gene, lipin1, that regulates axon regeneration in the CNS, offering new hope for treating spinal cord injuries.
- In August 2024, researchers from the University of Cincinnati developed a novel nerve guidance conduit to provide electrical, chemical, and physical cues to growing cells and nerves, thereby promoting nerve regeneration and repair.
- In May 2024, researchers from the Korea University College of Medicine and Sungkyunkwan University developed a novel “sticky and strain-gradient artificial epineurium” that presents a significant breakthrough in nerve repair surgery with enhanced efficacy in rapidly healing severed nerves without surgical microsurgery suturing techniques.
If you have any questions, please feel free to contact us at
